aTyr Pharma Strengthens Board of Directors with Appointment of Dr. Sara Zaknoen
aTyr Pharma, Inc. (LIFE)
Last atyr pharma, inc. earnings: 3/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
atyrpharma.com/investors-media
Company Research
Source: GlobeNewswire
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the appointment of Sara Zaknoen, M.D., to the company’s Board of Directors. Dr. Zaknoen is an experienced pharmaceutical drug development and clinical research executive having previously served as Chief Medical Officer at several biotech companies. “We are very pleased to welcome Sara, a highly accomplished executive with experience in drug development, to our Board of Directors,” said Sanjay S. Shukla, M.D., M.S., President and Chief Executive Officer of aTyr. “While we work toward the readout of our proof-of-concept study for our lead therapeutic candidate, ATYR1923, in pulmonary sarcoidosis in the third quarter of this year, we also continue to further our pipeline of antibodies targeting Neuropilin-2, including ATYR2810, which is in preclinical development for
Show less
Read more
Impact Snapshot
Event Time:
LIFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIFE alerts
High impacting aTyr Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
LIFE
News
- aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma to Participate in April Investor ConferencesGlobeNewswire
- aTyr Pharma, Inc. (NASDAQ: LIFE) had its price target lowered by analysts at Royal Bank of Canada from $19.00 to $16.00. They now have an "outperform" rating on the stock.MarketBeat
- aTyr Pharma Full Year 2023 Earnings: Revenues Disappoint [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
LIFE
Earnings
- 3/14/24 - Miss
LIFE
Sec Filings
- 4/5/24 - Form ARS
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- LIFE's page on the SEC website